CLASS III Device recall · Reported 10 Apr 2019 · FDA Enforcement Report

McKesson Consult Diagnostic Immunochemical Fecal Occult recalled

Cypress Medical Products is recalling McKesson Consult Diagnostic Immunochemical Fecal Occult Blood Test, Part numbers, distributed in 27 states. The recall was initiated on 27 Feb 2019 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesAll lots
Quantity recalled1165 cases

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1080-2019
FDA event ID
82312
Recalling firm
Cypress Medical Products, Richmond, VA
Classification
Class III
Status
Terminated
Recall initiated
27 Feb 2019
FDA classified
30 Mar 2019
Reported
10 Apr 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

27 Feb 2019Recall initiated by company
30 Mar 2019Classified by FDA+31 days
10 Apr 2019Published in enforcement report+11 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Products were denied Clinical Laboratory Improvement Amendments (CLIA) waiver approval by the FDA, due to the packaging being too similar to domestically sourced products under the same branded label.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

McKesson Consult Diagnostic Immunochemical Fecal Occult Blood Test, Part numbers 178-CK30T, 178-CT30, 178¿TBSO, 178-CM25, 178-CK50, 178-CM50, 178-CT50, 178¿CK30

Where it was distributed

Shipped to distribution centers located in AL, AR, AZ, CA, CO, FL, GA, HI, IL, KY, LA, MA, MN, MO, MS, NH, NJ, NY, OH, PA, SC, TN, TX, UT, VA, WA, and WI.

AlabamaArkansasArizonaCaliforniaColoradoFloridaGeorgiaHawaiiIllinoisKentuckyLouisianaMassachusettsMinnesotaMissouriMississippiNew HampshireNew JerseyNew YorkOhioPennsylvania

Questions about this recall

Why was it recalled?

Products were denied Clinical Laboratory Improvement Amendments (CLIA) waiver approval by the FDA, due to the packaging being too similar to domestically sourced products under the same branded label.

Which lots are affected?

All lots

Where was it sold?

Shipped to distribution centers located in AL, AR, AZ, CA, CO, FL, GA, HI, IL, KY, LA, MA, MN, MO, MS, NH, NJ, NY, OH, PA, SC, TN, TX, UT, VA, WA, and WI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cypress Medical Products

All 11

Other Test Kits & Diagnostics recalls

All 2,656